Curidium Medica plc
Curidium Medica plc is a company in the field of personalised medicine, focused on identifying targeted medicines and companion diagnostics to treat patients more effectively. Curidium’s initial focus on diseases of the central nervous system has resulted in the identification of a blood diagnostic test, PsychINDx, which classifies patients with schizophrenia/bipolar disorder into four subgroups. PsychINDx may have the potential to improve the treatment of patients with schizophrenia/bipolar disorder.
BUYING SIGNAL: speculative buy
COMPANY NAME: Curidium Medica plc
COMPANY TICKER: CUR.L
COUNTRY: United Kingdom
Log in or Register
This material is for members and clients only.Register Now